Opko Health, Inc.
OPK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000944809
No open-market purchases or sales by Opko Health, Inc. insiders were filed in the last 90 days; 222 institutions reported holding it in 13F filings for Q2 2026, worth $303.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Opko Health, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- −10 vs. Q2 2022
- Shares held
- 185.0M
- −4.73M (−2.5%) vs. Q2 2022
- Total value
- $349.6M
- −$130.3M (−27.1%) vs. Q2 2022
- New holders
- 22
- 68 more added
- Sold out
- 32
- 57 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 222 | $303.4M |
| Q1 2026 | 236 | $229.4M |
| Q4 2025 | 221 | $251.1M |
| Q3 2025 | 233 | $303.6M |
| Q2 2025 | 222 | $270.4M |
| Q1 2025 | 255 | $401.4M |
| Q4 2024 | 235 | $290.3M |
| Q3 2024 | 234 | $278.1M |
| Q2 2024 | 232 | $227.7M |
| Q1 2024 | 224 | $190.7M |
| Q4 2023 | 218 | $256.6M |
| Q3 2023 | 225 | $267.6M |
| Q2 2023 | 230 | $375.6M |
| Q1 2023 | 227 | $259.3M |
| Q4 2022 | 221 | $224.8M |
| Q3 2022 | 221 | $349.6M |
| Q2 2022 | 231 | $479.9M |
| Q1 2022 | 229 | $671.0M |
| Q4 2021 | 236 | $914.8M |
| Q3 2021 | 206 | $668.9M |
| Q2 2021 | 234 | $773.3M |
| Q1 2021 | 239 | $817.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Opko Health, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 2,043,330 | $3.86M | 0.00% | +119,338+6.2% | Added |
| Two Sigma Advisers, LP | 2,122,397 | $4.01M | 0.01% | +1,275,600+150.6% | Added |
| Millennium Management LLC | 2,142,184 | $4.05M | 0.01% | −5,248,251−71.0% | Reduced |
| Citigroup Inc | 2,142,392 | $4.05M | 0.01% | −25,221−1.2% | Reduced |
| Nuveen Asset Management, LLC | 2,201,636 | $4.16M | 0.00% | −483,570−18.0% | Reduced |
| Deutsche Bank AG | 2,280,181 | $4.31M | 0.00% | +751,958+49.2% | Added |
| JPMorgan Chase & Co | 2,374,176 | $4.49M | 0.00% | +344,713+17.0% | Added |
| Goldman Sachs Group Inc | 2,806,554 | $5.30M | 0.00% | +185,071+7.1% | Added |
| Renaissance Technologies LLC | 2,836,343 | $5.36M | 0.01% | −1,053,829−27.1% | Reduced |
| Two Sigma Investments, LP | 2,887,369 | $5.46M | 0.02% | +1,191,429+70.3% | Added |
| Norges Bank | 3,233,385 | $6.11M | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 3,372,129 | $6.37M | 0.00% | +706,353+26.5% | Added |
| Charles Schwab Investment Management Inc | 3,813,530 | $7.21M | 0.00% | +420,857+12.4% | Added |
| Northern Trust Corp | 3,905,354 | $7.38M | 0.00% | −1,162,543−22.9% | Reduced |
| Oracle Investment Management Inc | 5,102,756 | $9.64M | 5.53% | −2,150,000−29.6% | Reduced |
| D. E. Shaw & Co., Inc. | 5,968,306 | $11.3M | 0.02% | −397,910−6.3% | Reduced |
| Geode Capital Management, LLC | 7,829,188 | $14.8M | 0.00% | +200,456+2.6% | Added |
| State Street Corp | 10,374,273 | $19.6M | 0.00% | +507,764+5.1% | Added |
| Dimensional Fund Advisors LP | 10,823,641 | $20.5M | 0.01% | +1,744,961+19.2% | Added |
| BlackRock Inc. | 34,508,003 | $65.2M | 0.00% | −502,344−1.4% | Reduced |
| Vanguard Group Inc | 40,284,773 | $76.1M | 0.00% | −2,296,471−5.4% | Reduced |
| Jump Financial, LLC | 0 | $0 | 0.00% | −660,608−100.0% | Sold out |
| Trellus Management Company, LLC | 0 | $0 | 0.00% | −590,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −335,123−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −285,778−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −252,200−100.0% | Sold out |
| Mark Asset Management LP | 0 | $0 | 0.00% | −186,441−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −168,562−100.0% | Sold out |
| Matrix Private Capital Group LLC | 0 | $0 | 0.00% | −106,086−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −97,796−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −81,997−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −51,710−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −38,129−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −33,700−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −25,909−100.0% | Sold out |
| Platform Technology Partners | 0 | $0 | 0.00% | −19,769−100.0% | Sold out |
| Fairfield, Bush & Co. | 0 | $0 | 0.00% | −17,245−100.0% | Sold out |
| Forum Financial Management, LP | 0 | $0 | 0.00% | −17,043−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −14,849−100.0% | Sold out |
| Quantum Financial Advisors, LLC | 0 | $0 | 0.00% | −11,491−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −11,552−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −9,829−100.0% | Sold out |
| Grandview Asset Management LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Clean Yield Group | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Cyrus J. Lawrence, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −425−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Steward Financial Group LLC | 0 | $0 | 0.00% | −177−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |